» Articles » PMID: 36007181

Ion Channels and Channelopathies in Glomeruli

Overview
Journal Physiol Rev
Specialty Physiology
Date 2022 Aug 25
PMID 36007181
Authors
Affiliations
Soon will be listed here.
Abstract

An essential step in renal function entails the formation of an ultrafiltrate that is delivered to the renal tubules for subsequent processing. This process, known as glomerular filtration, is controlled by intrinsic regulatory systems and by paracrine, neuronal, and endocrine signals that converge onto glomerular cells. In addition, the characteristics of glomerular fluid flow, such as the glomerular filtration rate and the glomerular filtration fraction, play an important role in determining blood flow to the rest of the kidney. Consequently, disease processes that initially affect glomeruli are the most likely to lead to end-stage kidney failure. The cells that comprise the glomerular filter, especially podocytes and mesangial cells, express many different types of ion channels that regulate intrinsic aspects of cell function and cellular responses to the local environment, such as changes in glomerular capillary pressure. Dysregulation of glomerular ion channels, such as changes in TRPC6, can lead to devastating glomerular diseases, and a number of channels, including TRPC6, TRPC5, and various ionotropic receptors, are promising targets for drug development. This review discusses glomerular structure and glomerular disease processes. It also describes the types of plasma membrane ion channels that have been identified in glomerular cells, the physiological and pathophysiological contexts in which they operate, and the pathways by which they are regulated and dysregulated. The contributions of these channels to glomerular disease processes, such as focal segmental glomerulosclerosis (FSGS) and diabetic nephropathy, as well as the development of drugs that target these channels are also discussed.

Citing Articles

Integrating genome-wide association studies and transcriptomics prioritizes drug targets for meningioma.

Liao W, Wang J, Zhong H, Wen S, Chen Y, Chen J Brain Commun. 2025; 7(2):fcaf053.

PMID: 40046334 PMC: 11880806. DOI: 10.1093/braincomms/fcaf053.


Targeting REDD1 in Podocytes: A Promising Strategy for Mitigating Diabetic Kidney Injury.

Bohovyk R, Staruschenko A Diabetes. 2025; 74(3):265-267.

PMID: 39977620 PMC: 11842596. DOI: 10.2337/dbi24-0042.


The Ca-actin-cytoskeleton axis in podocytes is an important, non-immunologic target of immunosuppressive therapy in proteinuric kidney diseases.

Hackl A, Weber L Pediatr Nephrol. 2025; .

PMID: 39856247 DOI: 10.1007/s00467-025-06670-z.


Genotype-Phenotype Correlations with TRPC6-Associated Podocytopathy.

Miao J, Zand L J Am Soc Nephrol. 2025; 36(2):177-180.

PMID: 39774909 PMC: 11801746. DOI: 10.1681/ASN.0000000598.


Predicting susceptibility to COVID-19 infection in patients on maintenance hemodialysis by cross-coupling soluble ACE2 concentration with lymphocyte count: an algorithmic approach.

Yuan S, Meng F, Zhou S, Liu X, Liu X, Zhang L Front Med (Lausanne). 2024; 11:1444719.

PMID: 39540040 PMC: 11558530. DOI: 10.3389/fmed.2024.1444719.


References
1.
Kim Y, Goyal M, Kurnit D, Wharram B, Wiggins J, Holzman L . Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int. 2001; 60(3):957-68. DOI: 10.1046/j.1523-1755.2001.060003957.x. View

2.
Wang Y, Ding J, Xia X, Lingle C . Consequences of the stoichiometry of Slo1 alpha and auxiliary beta subunits on functional properties of large-conductance Ca2+-activated K+ channels. J Neurosci. 2002; 22(5):1550-61. PMC: 6758889. View

3.
Kong W, Haschler T, Nurnberg B, Kramer S, Gollasch M, Marko L . Renal Fibrosis, Immune Cell Infiltration and Changes of TRPC Channel Expression after Unilateral Ureteral Obstruction in Trpc6-/- Mice. Cell Physiol Biochem. 2019; 52(6):1484-1502. DOI: 10.33594/000000103. View

4.
Zuckerman J, Gale A, Wu P, Ma R, Davis M . siRNA delivery to the glomerular mesangium using polycationic cyclodextrin nanoparticles containing siRNA. Nucleic Acid Ther. 2015; 25(2):53-64. PMC: 4376487. DOI: 10.1089/nat.2014.0505. View

5.
Stockand J, Sansom S . Glomerular mesangial cells: electrophysiology and regulation of contraction. Physiol Rev. 1998; 78(3):723-44. DOI: 10.1152/physrev.1998.78.3.723. View